Disease outbreak prediction startup Metabiota has raised $30 million in Series A funding to help build out its offerings to government organizations and insurers on a global scale.
The San Francisco startup uses computer modeling to predict and prevent disease outbreaks in populations throughout the world, including Africa and Asia. It does this by collecting data from various communities and regional clinics to map out where a disease might strike next. Metabiota technology played a role in helping the Sierra Leone government stem Ebola outbreaks in the country.
Understanding pain is still a major challenge for millions of doctors and patients around the world: How severe is a patient’s pain? Can the level of pain tell the physician something about the patient’s condition?
An Israeli biomed startup called Medasense has developed a technology that mathematically measures pain in order to give doctors the best assessments. And that’s why last week, the company was announced as one of two winners of the startup competition at the Israel Advanced Technology Industries (IATI) Biomed Conference.
Pharma firms need better incentives to create novel antibiotics to head off an ‘apocalyptic scenario’ where commonplace infections become deadly once more. And the latest report from economist Jim O’Neill, who has been commissioned by the UK government to investigate how to tackle antimicrobial resistance (AMR), offers two ways to make developing antibiotics more attractive to industry. He recommends rewarding firms that develop a new antibiotic with a substantial lump sum. Secondly, a global innovation fund should be set up with $2 billion (£1.3 billion) to be invested over five years to boost blue skies research into drugs and diagnostics.
A Mediterranean diet with extra nuts and olive oil might help improve memory in older adults, a Spanish study suggests, though the results aren't definitive and more research is needed.
"This small study found that a Mediterranean diet, which is low in animal foods like meat and butter, and high in vegetables, legumes and whole grains, when supplemented with olive oil or nuts is associated with improved cognitive function," Samantha Heller, a nutritionist at New York University's Center for Musculoskeletal Care and Sports Performance who wasn't involved in the study, said by email.
If you want to feel better every day; move better every moment and compete at the highest level, support this crowdfunding campaign. We need your help.
Your contributions will jump start our new manufacturing process to reduce our costs –costs which we will pass on to you as lower pricing. For a limited time, pre-orders are offered at $199. That’s 60% off our current price.
L'entreprise de textiles japonaise Toyobo, qui dédie une part de son activité aux biomatériaux et réactifs utilisables en médecine, vient de mettre au point un matériau ayant pour but de favoriser la régénération osseuse au niveau de la mâchoire et des dents.
There are millions of Americans who battle depression every year and many of them fail to respond to pills and other standard treatments or suffer from side effects. “This group of patients often lives in agony, but we thought there must be another way to treat depression,” says Dr. Mark Demitrack, chief medical officer of Neuronetics. “What if you could stimulate the brain from the outside, without drugs, and make it heal?”
Health information integration platforms, especially consumer-focused ones, were mostly talk last year, but in 2015 the technology is being put into practice.
One platform company, Validic, has now secured a $12.5 million funding round led by Kaiser Permanente Ventures, the corporate venture capital arm of managed care giant Kaiser Permanente. A funding by Kaiser is seen as an important seal of approval in health circles.
Validic, headquartered in Mountain View, California, and Durham, N.C., said it’ll use the new money to continue to add staff, build products, and increase the number of devices reached by its platform.
A herbal tea that could combat malaria is due to start its first clinical trial in July, researchers have announced.
The brew, called Saye, will be trialled against the conventional malaria drug artemisinin with funding from the Ministry of Health in Burkina Faso. The Saye tea has been used in the country for more than 30 years.
Scanadu, the company behind the ‘medical tricorder’ device that broke crowdfunding records, has raised a $35 million round of venture funding to push its product into the marketplace.
The Silicon Valley company’s flagship product is a small, round device that lets people track their vitals at home. But the company says it’s actually building a whole family of mobile medical products for consumers.
